Study on the mechanism of Shujin Tongluo granules in treating cervical spondylosis based on network pharmacology and molecular docking

被引:1
|
作者
Wang, Yixuan [1 ]
Tao, Xiaoyu [1 ]
Gao, Yifei [1 ]
Jin, Zhengsen [1 ]
Guo, Siyu [1 ]
Li, Zhenjiang [2 ]
Wang, Mengmeng [3 ]
Zhao, Ruoqi [1 ]
Zhou, Wei [4 ]
Wu, Jiarui [1 ,5 ]
机构
[1] Beijing Univ Chinese Med, Sch Chinese Mat Med, Dept Clin Chinese Pharm, Beijing, Peoples R China
[2] Shineway Pharmaceut Grp Ltd, Shijiazhuang, Peoples R China
[3] World Federat Chinese Med Soc, Beijing, Peoples R China
[4] China Japan Friendship Hosp, Beijing, Peoples R China
[5] Beijing Univ Chinese Med, Sch Chinese Mat Med, Dept Clin Chinese Pharm, Beijing 102401, Peoples R China
基金
中国国家自然科学基金;
关键词
cervical spondylosis; mechanism of action; network pharmacology; Shujin Tongluo granules; PREDICTION;
D O I
10.1097/MD.0000000000034030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:To investigate the potential active ingredients and possible mechanisms of Shujin Tongluo granules (SJTLG) in the treatment of cervical spondylosis (CS) by network pharmacology and molecular docking. Methods:The active ingredients and potential targets of SJTLG were obtained through databases such as traditional Chinese medicine system (TCMSP) and BATMAN-traditional Chinese medicine (TCM), and the relevant human targets of CS were identified through databases such as OMIM, GeneCards, and DisGeNET. The intersection targets were imported into STRING for protein-protein interaction (PPI) analysis. The obtained data were imported into Cytoscape 3.9.0 software for visualization, and module analysis was performed using the MCODE plug-in. The representative targets were screened through the Metascape website for pathway enrichment analysis in Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Cytoscape software was used to build networks such as "drug-compound-target" and "drug-compound-target-pathway." Finally, the key targets were selected for molecular docking with the corresponding compounds by Autodock Tools 1.5.7 and visualized by PyMol. Results:A total of 132 active compounds and 996 targets from SJTLG and 678 targets from CS were screened with 116 intersection targets. The key targets were AKT1, GAPDH, ALB, IL-6, TP53, TNF, VEGFA, IL-1 & beta;, EGFR, HSP90AA1, ESR1, and JUN. The results of GO and KEGG enrichment analysis showed that the treatment of CS was mainly related to biological processes such as cellular response to nitrogen compound, cellular response to organonitrogen compound, and positive regulation of locomotion, and the targets were mainly focused on pathways in cancer, Kaposi sarcoma-associated herpesvirus infection, PI3K-Akt signaling pathway, lipid, and atherosclerosis. Molecular docking results showed that the minimum binding energy between the core targets and the corresponding compound was Conclusion:This study preliminarily elucidates the potential active ingredients and mechanism of anti-inflammatory, analgesic, microcirculation improvement, vasodilation, osteoporosis inhibition and nerve nutrition effects of SJTLG in the treatment of CS and provides a reference for its clinical application.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Study on the Antianxiety Mechanism of Suanzaoren Decoction Based on Network Pharmacology and Molecular Docking
    Xu, Xiaocong
    Gao, Bingbing
    Li, Xiongying
    Lei, Shanshan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [32] Study on the Mechanism of Chinese Medicine in Treating Cervical Spondylosis
    Liu, Jiayi
    Liu, Tong
    Qian, Xin
    Ma, Dongyang
    Chen, Lili
    Li, Ailin
    Liang, Xurong
    Hu, Zhe
    Qi, Chenxi
    Qi, Wei
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 86 : 310 - 318
  • [33] The Mechanism Study of Common Flavonoids on Antiglioma Based on Network Pharmacology and Molecular Docking
    Li, Taiping
    Xiao, Yong
    Wang, Zhen
    Xiao, Hong
    Liu, Hongyi
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [34] The mechanism of Zhenzhu Pills treating intracerebral hemorrhage secondary injury based on network pharmacology and molecular docking
    Wu, Gang
    Ren, Zeng
    Hao, Qingpei
    Wong, Yu
    Zha, Duo
    Cao, Xudong
    Liu, Ruen
    MEDICINE, 2024, 103 (07) : E36837
  • [35] Decoding the Mechanism of CheReCunJin Formula in Treating Sjogren's Syndrome Based on Network Pharmacology and Molecular Docking
    Xu, Xiaoyu
    Wang, Linshuang
    Chen, Qian
    Wang, Zikang
    Pan, Xun
    Peng, Xike
    Wang, Miao
    Wei, Dongfeng
    Li, Yanping
    Wu, Bin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [36] Exploring the mechanism of SLXG for treating nonalcoholic fatty liver disease based on network pharmacology and molecular docking
    Wang, Yang
    Wang, Jiaxing
    Chen, Zitong
    Liu, Bin
    Wang, Wujie
    Li, Yuliang
    MEDICINE, 2025, 104 (06)
  • [37] Mechanism of Polygala-Acorus in Treating Autism Spectrum Disorder Based on Network Pharmacology and Molecular Docking
    Chen, Haozhi
    Zhou, Changlin
    Li, Wen
    Bian, Yaoyao
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2024, 20 (07) : 1087 - 1099
  • [38] Decoding the Mechanism of Shixiao Powder in Treating Coronary Heart Disease Based on Network Pharmacology and Molecular Docking
    Jiang, Zuo-min
    Wu, Tong
    Xue, Yi-tao
    Li, Yan
    Li, Gui-hua
    Huang, Kai
    Yuan, Hua-jing
    Du, Meng-qi
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [39] Exploring the mechanism of ShenGui capsule in treating heart failure based on network pharmacology and molecular docking: A review
    Luo, Xiang
    Shi, Yunke
    Ma, Yiming
    Liu, Yixi
    Jing, Pan
    Cao, Xingyu
    Wang, Jincheng
    Hu, Zhao
    Cai, Hongyan
    MEDICINE, 2024, 103 (14)
  • [40] Detecting potential mechanism of vitamin D in treating rheumatoid arthritis based on network pharmacology and molecular docking
    Xu, Xiaoyu
    Luo, Hongyu
    Chen, Qian
    Wang, Zikang
    Chen, Xixuan
    Li, Xiaping
    Chen, Huan
    Wang, Miao
    Xu, Yingyue
    Dai, Min
    Wang, Jianwei
    Huang, Xuekuan
    Wu, Bin
    Li, Yanping
    FRONTIERS IN PHARMACOLOGY, 2022, 13